News and Stories About molecular profiling
Stage IV Survivor Doing Well Thanks to Clinical Trial
Editor’s note: January is Pancreatic Cancer Clinical Trials Awareness Month. Today we share the experience of a stage IV pancreatic […]
READ MORE
2019 Year in Review: Progress in Research
Editor’s note: This article kicks off our 2019 Year in Review series – highlighting the research advancements that you – […]
READ MORE
Survivor Gains Some Control with Targeted Treatment
In early 2018, Mary Fox “felt on top of the world.” She and her husband of 40 years, Craig, had […]
READ MORE
Matched Therapy Increases Pancreatic Cancer Survival
People with pancreatic cancer and a specific type of change – or mutation – in their DNA live longer when […]
READ MORE
34-year-old Survivor Responds Well to Targeted Therapy
When Adam Deal was getting ready for his fraternity brother’s wedding in September 2017, he found himself “practically swimming” in […]
READ MORE
Comparing Pancreatic Tumor Tissue Types for Molecular Profiling
When the Pancreatic Cancer Action Network (PanCAN) launched its Know Your Tumor® precision medicine service, molecular profiling was offered for […]
READ MORE
What Is Cancer Immunotherapy?
Cancer immunotherapy involves empowering the patient’s immune system to recognize, attack and destroy cancer cells. While remarkable results have been […]
READ MORE
5 Things to Know About Precision Medicine
Every pancreatic tumor – and every pancreatic cancer patient – is different. The Pancreatic Cancer Action Network (PanCAN) strongly recommends […]
READ MORE
Positive Clinical Trial Results Presented at Major Oncology Conference
This year’s American Society of Clinical Oncology (ASCO) Annual Meeting has brought 40,000 oncologists and other cancer experts from around […]
READ MORE
What You Need to Know Before a Pancreatic Biopsy
An imaging test may find a tumor on the pancreas, which could be benign (non-cancerous) or malignant (cancerous). Getting a […]
READ MORE
Guidelines Advise Germline and Somatic Testing
Editor’s note: The National Comprehensive Cancer Network (NCCN), which sets guidelines for the treatment and management of pancreatic adenocarcinoma (the […]
READ MORE
PanCAN Leader ‘Blown Away’ by Cancer Conference
“I’ve been attending the American Association for Cancer Research (AACR) annual meetings for several years, and this year’s conference was […]
READ MORE
Lynch Syndrome and Pancreatic Cancer Risk
About 10 percent of pancreatic cancer cases are thought to be hereditary – caused by an inherited genetic alteration that […]
READ MORE
Large-scale Molecular Profiling Reveals Clues About Pancreatic Tumors and Cysts
The largest-ever molecular analysis of pancreatic cancer tissue samples – from more than 3,500 patients – revealed some new clues […]
READ MORE
Young Mom with Pancreatic Cancer Advocates for Herself
When Allison Perlis of Potomac, Md., first began experiencing symptoms of pancreatic cancer in early 2017, she dismissed them as […]
READ MORE
Moments Matter: Karen Kiernan
Around Christmas 2016, Karen Kiernan was enjoying the holidays at her family home in Truckee, Calif., when she began to […]
READ MORE
TIME Features Importance of Right Team, Tests, Treatment Post-Diagnosis
A recently published article on TIME.com highlights important steps patients should take after a cancer diagnosis and mentions that the […]
READ MORE
Precision Medicine Panel Champions Collaborative Learning and Partnerships
Last week, Jenny Isaacson, vice president of strategic partnerships and projects at the Pancreatic Cancer Action Network (PanCAN), championed cross-sector […]
READ MORE
2018 Year in Review: Progress in Research, Part 1
Editor’s note: Welcome to the first article in our 2018 Year in Review series! Over the next couple weeks, we’ll […]
READ MORE
Survivor Fights Pancreatic Cancer with Genetics
Elise Tedeschi was shocked when she was diagnosed with stage IV pancreatic cancer. She was only 42 years old, enjoying […]
READ MORE
New Cancer Drug Approved Based on Molecular Profiling
The U.S. Food and Drug Administration (FDA) approved Vitrakvi® (larotrectinib) today for the treatment of any locally advanced or metastatic solid tumor, […]
READ MORE
PanCAN’s President and CEO Featured at People v. Cancer Event
The Atlantic’s People v. Cancer event took place Nov. 14, 2018, in New York City. The event featured a stellar […]
READ MORE
Ask Patient Central: Molecular Profiling
The Pancreatic Cancer Action Network (PanCAN) offers an Ask Patient Central series to provide helpful tips and information about commonly […]
READ MORE
1,000th Patient Receives Know Your Tumor® Report
The Pancreatic Cancer Action Network (PanCAN) has now delivered personalized molecular profiling reports to 1,000 pancreatic cancer patients through its […]
READ MORE
Wall Street Journal Reports How Genetics Affect Risk and Treatments
“I was 7 years old when my dad’s mom, Gertrud, was diagnosed with breast cancer,” began Pamela Munster, MD, a […]
READ MORE
Persistence, Precision Medicine Pay off for Pancreatic Cancer Patient
When doctors told David Watson of Santa Monica, Calif., that he had type 2 diabetes in November 2016, he couldn’t […]
READ MORE
What Are Pancreatic Cancer Biomarkers?
A biomarker is a substance found in the body that can be measured. The amount of a biomarker may vary […]
READ MORE
Read How Allison Got on the Right Track
Editor’s note: Allison Lippman got on the Right Track. Learn more. Before Allison Lippman of Dallas met her now-husband, she […]
READ MORE
What You Need to Know About Genetic and Molecular Testing
Editor’s note: Knowledge is power, but keeping up with all the different types of genetic and molecular tests and profiling […]
READ MORE
New Research Suggests Age May Benefit Response to Immunotherapy
Cancer immunotherapy involves efforts to harness the patient’s own immune system to recognize and attack tumor cells. To date, the […]
READ MORE
PanCAN Publishes Hopeful Precision Medicine Results
Published today in the esteemed Clinical Cancer Research, a journal of the American Association for Cancer Research, the Pancreatic Cancer […]
READ MORE
Novel study urges genetic testing for all pancreatic cancer patients, creating a new standard of care
With the Identification of Six Genetic Mutations, Authors Urge Genetic Testing for All Pancreatic Cancer Patients – Not Only Those […]
READ MORE
New Study Encourages Genetic Testing for All Pancreatic Cancer Patients, Regardless of Family History
A pancreatic cancer diagnosis can lead to a lot of questions, including how to choose a healthcare team, deciding on […]
READ MORE
Institution’s Molecular Profiling Results Affect Clinical Decisions
Every pancreatic tumor is different. The Pancreatic Cancer Action Network (PanCAN) strongly recommends molecular profiling of your tumor to help […]
READ MORE
Pancreatic Cancer Treatment Myths Uncovered
It is important to know all your treatment options at every stage of your pancreatic cancer diagnosis. Here are five […]
READ MORE
Clinical Guidelines for Metastatic Disease Updated
The American Society of Clinical Oncology (ASCO) has updated their treatment guidelines for patients with metastatic pancreatic cancer, or disease […]
READ MORE
New Treatment Guidelines to Improve Patient Options
Editor’s note: Below we describe recent updates to the National Comprehensive Cancer Network’s (NCCN) guidelines for the treatment and management […]
READ MORE
Celebrate National DNA Day with Five Key Facts
Did you know that DNA gets its own day? It’s today! National DNA Day has been celebrated for the past […]
READ MORE
More than 20,000 Cancer Researchers Converge at International Meeting
The theme for this year’s American Association for Cancer Research (AACR) Annual Meeting, which took place earlier this week in […]
READ MORE
CEO Fleshman Applauds Myeloma Founder’s Efforts in Forbes
In a recent Forbes article, “She Was Given Three Years To Live. So She Transformed Cancer Research,” Pancreatic Cancer Action […]
READ MORE
National Doctors’ Day: Honoring Roles and Importance of Specialists
Editor’s note: Today is National Doctors’ Day, and we are celebrating the critical roles of various specialists in the diagnosis […]
READ MORE
NPR Focuses on One of the Biggest Challenges in Pancreatic Cancer: KRAS
About 95 percent of pancreatic cancer cases – and around 30 percent of all human cancers – have a mutation […]
READ MORE
Precision Medicine Highlighted in the News
“All Cancer Patients Should Have Access To Genomic Testing” is the title of a compelling article featured in Forbes earlier […]
READ MORE
2017 Year in Review: Top 10 News Stories
Editor’s note: This article is another installment in our “Year in Review” series recapping the year’s top stories in pancreatic […]
READ MORE
Keytruda Drug Is Science Breakthrough of the Year Runner-up
At the end of every year, Science magazine announces a Breakthrough of the Year – a discovery that revolutionized the […]
READ MORE
2017 Year in Review: Progress in Research, Part 1
Editor’s note: This article is the first in our “Year in Review” series recapping the year’s top stories in pancreatic […]
READ MORE
Discovery of Rare Mutation Gives Survivor Options, Hope
Akshay Mehta, MD, was in the middle of performing an orthopedic surgery when his first pancreatic cancer symptom arose. “I […]
READ MORE
Tumor’s Genetic Changes Can Impact Patient Outcomes
Among the many genetic mutations and molecular alterations that can be found in pancreatic tumors, there are four that are […]
READ MORE
Going Beyond Standard of Care
Pancreatic cancer is difficult to treat. There are a few standard treatments, but there are additional options that we encourage […]
READ MORE
Pancreatic Cancer in U.S. News & World Report
“Let’s face it: The pancreas is a behind-the-scenes organ most of us don’t know – or think – much about. […]
READ MORE
Tempus Invests in Innovative Cancer Technology
Congratulations to Pancreatic Cancer Action Network (PanCAN) partner Tempus, a technology company building the world’s largest library of molecular and […]
READ MORE
Progress Report: ‘Research Continues to Be Our Best Defense Against Cancer’
The American Association for Cancer Research (AACR) released its annual Cancer Progress Report earlier this week. “Research continues to be […]
READ MORE
Nationwide Effort Uncovers Genetic Clues in Pancreatic Cancer Cells
The cleverly named The Cancer Genome Atlas project – abbreviated TCGA, in homage to the four base pairs that make […]
READ MORE
New Study Evaluates Molecular Profiling for Pancreatic Cancer Patients
Every pancreatic tumor is different. The Pancreatic Cancer Action Network strongly recommends molecular profiling of your tumor to help determine […]
READ MORE
Recent Precision Medicine Developments Showing Promise of Field
May was a busy month for pancreatic cancer precision medicine developments. Every pancreatic tumor is different. The Pancreatic Cancer Action […]
READ MORE
Unprecedented Drug Approval Can Benefit Pancreatic Cancer Patients
For the first time, the U.S. Food and Drug Administration (FDA) has approved a cancer drug based only on molecular […]
READ MORE
Rare but Targetable Genetic Change Discovered in Pancreatic Cancer Patients
The Pancreatic Cancer Action Network’s state-of-the-art Know Your Tumor® precision medicine service offers molecular profiling to eligible patients. Molecular profiling […]
READ MORE
Clinical Trials Are Recommended During Every Treatment Decision
Making treatment decisions may be overwhelming. We want to make sure you have the information you need, every step of […]
READ MORE
Leading Oncologist Champions Treatment Progress Through Personalized Medicine
Dr. Andrew E. Hendifar, the medical oncology lead for the gastrointestinal disease research group at Cedars-Sinai Medical Center, champions progress […]
READ MORE
Study Shows Biomarker-Based Treatment Provides Best Results
We’ve learned a lot about pancreatic cancer in recent years, and we now know that every patient’s cancer is different […]
READ MORE
